Orexigen Falls After Halting Development of Diet Pill in U.S.
“The agency has always been clear with companies developing weight–loss products that we will weigh the drug's potential benefits with the potential risks,” Erica Jefferson, a spokeswoman for the FDA, said today in an e-mail. …
See all stories on this topic »